Skip to page content

Institutional Biosafety Committee (IBC)

Responsibilities of the University

For any project involving the use of recombinant DNA molecules, Tarleton State University assumes primary responsibility for complying with both the intent and the procedures of the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant DNA Molecules. This responsibility includes:

  • Ensuring a standing Institutional Biosafety Committee (IBC) is maintained in accord with Part IV of the NIH Guidelines and also ensuring the research plan is reviewed and approved by the IBC prior to beginning substantive work under the project.
  • Registering all experiments involving recombinant DNA molecules conducted with funds provided under the project and complying with the containment requirements specified in Part II of the NIH Guidelines. Records of this research must be kept in a form that is readily available to grant sponsors.
Institutional Biosafety Committee Members
Name Position Phone
Dr. Janice Speshock Chairman, Assistant Professor, Department of Biological Sciences 254-968-9341
Ernie Bramlett Non-Affiliated Member  
Rusty Crum Non-Affiliated Member  
Dr. Kristin Herrmann Assistant Professor, Department of Biological Sciences 254-968-9469
Dr. Sally Lewis Department Head, Department of Medical Lab Sciences 254-968-7222
Mark Murphy Laboratory Manager, TIAER 254-968-9570
Dr. James Pierce Dean, College of Science and Technology 254-968-9781
Dr. Harold Rathburn Associate Professor, Department of Biological Sciences 254-968-9147
Dr. Jason Sawyer Assistant Professor, Department of Animal Science and Veterinary Technology 254-968-1836
Dr. Barry Lambert Ex-Officio, Associate Vice President for Research 254-968-9463

Use of Recombinant DNA

For any project involving the use of recombinant DNA molecules, Tarleton State University assumes primary responsibility for complying with both the intent and the procedures of the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant DNA Molecules. This responsibility includes:

  • Ensuring a standing Institutional Biosafety Committee (IBC) is maintained in accord with Part IV of the NIH Guidelines and also ensuring the research plan is reviewed and approved by the IBC prior to beginning substantive work under the project.
  • Registering all experiments involving recombinant DNA molecules conducted with funds provided under the project and complying with the containment requirements specified in Part II of the NIH Guidelines. Records of this research must be kept in a form that is readily available to grant sponsors.

Responsibilities of the Principal Investigator

  • Being aware of recombinant DNA biosafety requirements and assuring that Tarleton's requirements and procedures are followed.
  • Assuring that all work involving recombinant DNA is registered with the IBC.
  • Assuring that necessary safeguards and procedures are maintained in the work place; and
  • Following the NIH Guidelines for Research Involving Recombinant DNA Molecules.

The Institutional Biosafety Committee (IBC) is responsible for reviewing, approving and maintaining a registry of research projects and/or proposals involving the use of recombinant DNA at Tarleton State University. The IBC also provides oversight, review and assessment of adherence to NIH requirements for recombinant DNA research; training and expertise of personnel; lab safety, security and biological containment practices; and emergency contingency plans, including containment and cleanup of spills and exposure of personnel to biohazardous materials.

Resources

Forms

All researchers engaged in sponsored research activities must fully and conspicuously disclose the identity of the research sponsor on or in any communications intended for public dissemination or use (Texas Education Code 51.954 and 51.955).

More Information